Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting.
COVID-19
Ecuador
Non-pharmaceutical interventions
SARS-CoV-2
public health
respiratory infections
Journal
Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
pubmed:
12
9
2023
medline:
12
9
2023
entrez:
12
9
2023
Statut:
ppublish
Résumé
Ecuador had substantial COVID-19-mortality during 2020 despite early implementation of non-pharmaceutical interventions (NPIs). Resource-limited settings like Ecuador have high proportions of informal labour which entail high human mobility, questioning efficacy of NPIs. We performed a retrospective observational study in Ecuador's national reference laboratory for viral respiratory infections during March 2020-February 2021 using stored respiratory specimens from 1950 patients, corresponding to 2.3% of all samples analysed within the Ecuadorian national surveillance system per week. During 2020, detection of SARS-CoV-2 (Pearson correlation;
Identifiants
pubmed: 37698611
doi: 10.1080/22221751.2023.2259001
pmc: PMC10563623
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2259001Références
J Infect. 2020 Dec;81(6):966-972
pubmed: 33207254
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Virus Evol. 2021 Jun 04;7(2):veab051
pubmed: 34527281
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Sci Adv. 2022 Jun 17;8(24):eabp8621
pubmed: 35714183
Int J Epidemiol. 2022 Feb 18;51(1):54-62
pubmed: 34387670
Nat Microbiol. 2022 Sep;7(9):1490-1500
pubmed: 35982313
Bioinformatics. 2016 Oct 15;32(20):3204-3206
pubmed: 27334476
Euro Surveill. 2021 Jul;26(28):
pubmed: 34269173
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33722793
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Clin Med (Lond). 2020 Sep;20(5):e163-e164
pubmed: 32620593
BMC Public Health. 2021 Sep 1;21(1):1607
pubmed: 34470630
J Infect Public Health. 2019 May - Jun;12(3):357-363
pubmed: 30573330
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nat Commun. 2021 Jan 19;12(1):434
pubmed: 33469026
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Health Policy Technol. 2020 Dec;9(4):525-559
pubmed: 32874863
Disaster Med Public Health Prep. 2022 Feb;16(1):51-54
pubmed: 32900417
Disasters. 2015 Jan;39(1):125-45
pubmed: 25243477
J Med Virol. 2020 Jul;92(7):841-848
pubmed: 32243599
Front Public Health. 2021 Nov 29;9:754696
pubmed: 34912768
PLoS One. 2020 Oct 7;15(10):e0239795
pubmed: 33027281
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Am J Trop Med Hyg. 2020 Nov;103(5):1765-1772
pubmed: 32940204
mSphere. 2021 Dec 22;6(6):e0068521
pubmed: 34817236
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7588-93
pubmed: 17416677
Lancet. 2021 Jul 10;398(10295):97-99
pubmed: 34115978
BMJ. 2020 Jul 15;370:m2743
pubmed: 32669358
Immunity. 2021 Dec 14;54(12):2681-2687
pubmed: 34910934
Lancet Reg Health Am. 2021 Dec;4:100086
pubmed: 34664040
J Med Virol. 2020 Aug;92(8):1316-1321
pubmed: 31769524
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Nat Hum Behav. 2022 Aug;6(8):1079-1086
pubmed: 35618779
Public Health. 2022 Oct;211:5-13
pubmed: 35988506
J Public Econ. 2021 Jan;193:104311
pubmed: 33262548
Vaccine. 2021 Apr 15;39(16):2183-2186
pubmed: 33752954
Virus Evol. 2021 Mar 20;7(1):veab020
pubmed: 33768964
PLoS One. 2021 Dec 28;16(12):e0261381
pubmed: 34962952
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Sci Transl Med. 2023 Jan 25;15(680):eabn7979
pubmed: 36346321